Country: Malaysia
Bahasa: Inggeris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
MEGESTROL ACETATE
HOVID BERHAD
MEGESTROL ACETATE
120 ml
WINSTON MEDICAL SUPPLY CO., LTD
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ HOVID-MEGESTROL ORAL SUSPENSION 40MG/ML MEGESTROL ACETATE, USP (40 MG) 1 WHAT IS IN THIS LEAFLET 1. What hovid-Megestrol Oral Suspension 40mg/ml is used for 2. How hovid-Megestrol Oral Suspension 40mg/ml works 3. Before you use hovid-Megestrol Oral Suspension 40mg/ml 4. How to use hovid-Megestrol Oral Suspension 40mg/ml 5. While you are using it 6. Side effects 7. Storage and Disposal of hovid- Megestrol Oral Suspension 40mg/ml 8. Product description 9. Manufacturer 10. Product Registration Holder 11. Date of revision 12. Serial number WHAT HOVID-MEGESTROL ORAL SUSPENSION 40MG/ML IS USED FOR hovid-Megestrol Oral Suspension 40mg/ml is indicated for the treatment of significant weight loss or intense fear of weight gain in both men and women. HOW HOVID-MEGESTROL ORAL SUSPENSION 40MG/ML WORKS Hovid-Megestrol Oral Suspension 40mg/ml reduce significant weight loss by enhancing appetite. BEFORE YOU USE HOVID-MEGESTROL ORAL SUSPENSION 40MG/ML _- When you must not use it _ Do not take this medicine if you: Allergic to megestrol acetate or any component of the formulation Are pregnant or may be pregnant Wish to take this medicine to prevent anticipated weight loss, but you are not having weight loss yet. _- Before you start to use it _ Tell your doctor if you: have diabetes, as megestrol acetate can increase your blood sugar levels have intolerance to some sugars _- Taking other medicines _ Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. HOW TO USE HOVID-MEGESTROL ORAL SUSPENSION 40MG/ML _- How much to use _ The recommended adult initial dosage of hovid-Megestrol Oral Suspension 40mg/ml is 400mg to 800 mg per day (10 ml to 20 ml per day). _- How to take it _ Shake container well before using. A 20ml plastic dosage cup with markings on every 2.5ml is provided for convenience. _- When to take it _ Take hovid-Megestrol Oral Suspension 40mg/ml with or without food. _ _ _- How long to take it _ Contin Baca dokumen lengkap
VIMEGxx-05 HOVID-MEGESTROL ORAL SUSPENSION 40 MG/ML xxx DESCRIPTION hovid-Megestrol Oral Suspension 40 mg/ml contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. It is a white to light yellow suspension. COMPOSITION Each ml contains megestrol acetate 40 mg. Each ml contains sodium benzoate 2 mg as preservatives. PHARMACODYNAMICS Several investigators have reported on the appetite enhancing property of megestrol acetate and its possible use in cachexia. The precise mechanism by which megestrol acetate produces effects in anorexia and cachexia is unknown at the present time. PHARMACOKINETICS ABSORPTION AND DISTRIBUTION Megestrol acetate plasma concentrations are dependent on the intestinal and hepatic inactivation of the drug, which may be affected by factors such as intestinal tract motility, intestinal bacteria, antibiotics administered, body weight, diet, and liver function. METABOLISM AND EXCRETION The major route of drug elimination of megestrol acetate in humans is urine. Metabolites have accounted for only 5% to 8% of an administered dose of megestrol acetate. The administered dose is usually excreted in the urine (approx. 66%) and faeces (approx. 20%). The effect of food on the bioavailability of hovid-Megestrol Oral Suspension 40 mg/ml is unknown. INDICATION hovid-Megestrol Oral Suspension 40 mg/ml is indicated in male and female patients for the treatment of anorexia or weight loss secondary to cancer or acquired immune deficiency syndrome. CONTRAINDICATIONS History of hypersensitivity to megestrol acetate or any component of the formulation. Known or suspected pregnancy. WARNING AND PRECAUTIONS WARNINGS Megestrol acetate may cause fetal harm when administered to a pregnant woman. There are no adequate and well-controlled studies in pregnant women. If this drug is used during pregnancy, or if the patient becomes pregnant while taking (receiving) this drug, the patient should be apprised of the potential hazard to the fetus. Women of childbearing pote Baca dokumen lengkap